首都医科大学学报 ›› 2026, Vol. 47 ›› Issue (1): 157-162.doi: 10.3969/j.issn.1006-7795.2026.01.020

• 临床研究 • 上一篇    下一篇

血钾变异性与维持性血液透析患者长期预后的相关性

马也娉,刘小菁,王小琪,李忠心*   

  1. 首都医科大学附属北京潞河医院肾病中心,北京  101100
  • 收稿日期:2025-06-06 修回日期:2025-09-17 出版日期:2026-02-21 发布日期:2026-02-02
  • 通讯作者: 李忠心 E-mail:hyy6806@ccmu.edu.cn
  • 基金资助:
    首都医科大学附属北京潞河医院研究者发起的临床研究项目(LHYY2024-YJZ013)。

Association of serum potassium variability and long-term prognosis in maintenance hemodialysis patients

Ma Yeping, Liu Xiaojing, Wang Xiaoqi,   Li Zhongxin*   

  1. Department of Nephrology, Beijing Luhe Hospital, Capital Medical University, Beijing 101100,China
  • Received:2025-06-06 Revised:2025-09-17 Online:2026-02-21 Published:2026-02-02
  • Supported by:
    This study was supported by A Clinical Study Initiated by Researchers of Beijing Luhe Hospital Affiliated with Capital Medical University(LHYY2024-YJZ013).

摘要: 目的  探讨血钾变异性与维持性血液透析(maintenance hemodialysis,MHD)患者长期预后的关系。方法  选取2018年1月在首都医科大学附属北京潞河医院血液透析中心接受MHD的患者为研究对象,并随访至2024年4月。血钾变异性定义为2017年1月至2017年12月血钾的变异系数。根据血钾变异系数的中位数分为高钾变异组(0.080 2~0.215 9)和低钾变异组(0.026 5~0.080 1),比较两组患者的临床特点。使用Kaplan-Meier绘制生存曲线,Log-rank检验比较两组间的生存率差异;用Cox比例风险模型分析血钾变异性与MHD患者全因死亡的关系。结果  本研究共纳入213例患者,其中58.2%为男性,平均年龄(59.1±13.4)岁,中位透析龄4.4(2.7, 6.9)年,中位随访时间6.0(2.5, 6.25)年。在随访期内,104例患者死亡,死亡率48.8%,其中心血管死亡52例(50.0%),感染死亡18例(17.3%),脑血管死亡15例(14.4%)。Kaplan-Meier曲线显示高钾变异组全因病死率高于低钾变异组(Log-rank,χ2=9.119,P=0.025)。多因素Cox回归分析显示,在调整了年龄、白蛋白、血肌酐、尿素清除指数(urea clearance index value, Kt/V)等潜在混杂因素后,高钾变异组全因死亡风险高于低钾变异性组(HR=1.537,95%CI:1.026~2.302)。结论  血钾变异性与MHD患者全因死亡相关。MHD患者应密切监测血钾水平及其变异性。

关键词: 血钾变异性, 终末期肾病, 维持性血液透析, 全因死亡, 预后, Cox回归

Abstract: Objective  To explore the correlation between serum potassium variability and long-term prognosis in maintenance hemodialysis patients (MHD). Methods  Baseline data were recruited from MHD patients treated at Beijing Luhe Hospital, Capital Medical University hemodialysis center in January 2018,with follow-up through April 2024.Variability of serum potassium was defined as the coefficient of variation of serum potassium from January 2017 to December 2017,and the statistical analysis was performed after log transformation. According to serum potassium variability, MHD patients were divided into the high potassium variability group(0.080 2-0.215 9)and the low potassium variability group(0.026 5-0.080 1). Kaplan-Meier survival analysis was used to obtain patient survival probabilities, multivariate Cox hazard regression model was used to explore the association between serum potassium variability and all-cause mortality. Results  A total of 213 patients were included in this study, 58.2% were males, with a mean age of (59.1±13.4) years, a median dialysis vintage of 4.4(2.7, 6.9) years,and the median observation period was 6.0 (2.5, 6.25) years. 104 patients(48.8%) died during the observation period, including 52 cardiovascular deaths (50.0%), 18 infectious deaths(17.3%),15 cerebrovascular deaths(14.4%). Kaplan-Meier curves showed that a higher potassium variability coefficient was associated with higher all-cause mortality (Log-rank,χ2=9.119,P=0.025).  After adjusting for potential confounding factors such as age, albumin, serum creatinine, and Kt/V(urea clearance index value), multivariate Cox regression analysis revealed that the high potassium variability group had a higher risk of all-cause mortality than the low potassium variability group (HR=1.537, 95% CI: 1.026-2.302, P=0.037). Conclusion  Higher serum potassium variability was associated with higher all-cause mortality in MHD patients. More attention should be paid to managing serum potassium levels and their fluctuations in MHD patients.

Key words: serum potassium variability, end-stage kidney disease, maintenance hemodialysis, all-cause mortality, prognosis, Cox regression

中图分类号: